66 Participants Needed

Social Dance Therapy for Early Alzheimer's Disease

MH
Overseen ByMadeleine Hackney, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Emory University
Must be taking: Aricept, Anticholinesterase inhibitors
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial requires that participants are not on medications that could negatively affect cognition, such as antipsychotics, opioids, stimulants, and certain drugs for Parkinson's and multiple sclerosis. Participants must also be on stable doses of medications like Aricept or Namenda for at least 3 months before joining the study.

What data supports the effectiveness of the treatment Social Dance Therapy for Early Alzheimer's Disease?

Research shows that rhythmic auditory cues and music therapy can improve walking speed and stride length in Alzheimer's patients, and dance-based treatments like Biodanza and Salsa have been effective in reducing agitation and improving balance and gait. Combining music and physical rehabilitation has also shown positive effects on cognitive and motor functions in Alzheimer's patients.12345

Is social dance therapy safe for people with Alzheimer's disease?

Research shows that social dance therapy, including programs like Salsa dance and music-cued gait training, is generally safe for people with Alzheimer's disease. Studies found no adverse events, and participants reported high satisfaction with the activities.12367

How is the Social Dance Therapy treatment for early Alzheimer's disease different from other treatments?

Social Dance Therapy, including Partnered Rhythmic Rehabilitation (PRR), is unique because it combines movement, social interaction, and cognitive stimulation, which can improve mood and behavior in people with early Alzheimer's disease. Unlike traditional drug treatments, this non-pharmacological approach focuses on enhancing quality of life through dance and social engagement.278910

What is the purpose of this trial?

Interventions that affect many different aspects of human ability rather than just one aspect of human health are more likely to be successful in preventing and treating Alzheimer's disease (AD). Functional decline in AD is severely impacted by impaired ability to do physical actions while having to make decisions and concentrating, something scientists call motor-cognitive integration. Combined motor and cognitive training has been recommended for people with early AD, thus this study will use partnered, rhythmic rehabilitation (PRR), as an intervention to simultaneously target cardiovascular, social and motor-cognitive domains important to AD. PRR is moderate intensity, cognitively-engaging social dance that targets postural control systems, involves learning multiple, varied stepping and rhythmic patterns, and fosters tactile communication of motor goals between partners, enhancing social interaction's effect on cognition. Previous research demonstrates that PRR classes are safe and result in no injurious falls.This study is a 12-month long Phase II single- blind randomized clinical trial using PRR in 66 patients with early AD. Participants with early AD will be randomly assigned to participate in PRR or a walking program for three months of biweekly sessions, followed by nine months of weekly sessions of PRR or walking. The overarching hypothesis is that PRR is safe, tolerable and associated with improved motor-cognitive function, and brain (neuronal), vascular (blood vessels) and inflammatory biomarkers that might affect function.

Research Team

MH

Madeleine Hackney, MD

Principal Investigator

Emory University

Eligibility Criteria

This trial is for individuals with early Alzheimer's Disease who can walk unaided, have a certain level of cognitive function and memory concern, completed at least six grades of education or have a solid work history, are not very physically active, and willing to commit to a year-long research program. Those with severe mental health issues, recent hospitalization or conditions that could interfere with the study cannot participate.

Inclusion Criteria

I have been diagnosed with mild memory loss (MCI) according to ADNI standards.
I can perform daily activities without significant assistance.
You have completed six grades of education or have a good work history.
See 12 more

Exclusion Criteria

I have had a stroke within the last three years.
I cannot undergo the procedures required in this study.
Inability to perform MRI (e.g. metal implants or cardiac pacemaker, claustrophobia)
See 7 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Training

Participants are assigned to 20 biweekly 90-minute lessons over 12 weeks, focusing on either PRR or WALK interventions.

12 weeks
20 visits (in-person)

Maintenance

Participants attend weekly lessons at least 3 times per month for 9 months, continuing with either PRR or WALK interventions.

9 months
At least 36 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after the intervention period.

4 weeks

Treatment Details

Interventions

  • Group walking (WALK)
  • Partnered Rhythmic Rehabilitation (PRR)
Trial Overview The trial tests Partnered Rhythmic Rehabilitation (PRR), which is social dance aimed at improving cardiovascular health, motor-cognitive functions and social interaction against group walking. It's a 12-month Phase II trial where participants do biweekly sessions for three months followed by weekly sessions for nine months.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Partnered Rhythmic Rehabilitation (PRR)Experimental Treatment1 Intervention
Participants in this study are will receive the PRR intervention. Participants will have two phases of intervention. In the three-month Training phase, participants will be assigned to 20, biweekly (90-minute) lessons over 12 weeks. In the nine-month Maintenance phase, participants will attend weekly lessons at least 3 times per month.
Group II: Group walking (WALK)Active Control1 Intervention
Participants in this study are will receive the WALK intervention. Participants will have two phases of intervention. In the three-month Training phase, participants will be assigned to 20, biweekly (90-minute) lessons over 12 weeks. In the nine-month Maintenance phase, participants will attend weekly lessons at least 3 times per month.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Emory University

Lead Sponsor

Trials
1,735
Recruited
2,605,000+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+

Findings from Research

An 84-year-old woman with multiple health issues, including Alzheimer's and a history of falls, participated in 24 Salsa dance therapy sessions over 12 weeks, leading to significant improvements in her balance, strength, and mobility.
After the therapy, she experienced only one fall during treatment with no injuries, and reported no falls six months later, suggesting that Salsa dance therapy may effectively reduce fall risk in older adults.
The effects of Salsa dance on balance, gait, and fall risk in a sedentary patient with Alzheimer's dementia, multiple comorbidities, and recurrent falls.Abreu, M., Hartley, G.[2022]
In a pilot study involving 16 institutionalized older adults with Alzheimer's disease, the Biodanza intervention, which is a nonpharmacological dance movement therapy, significantly reduced agitation and neuropsychiatric behaviors.
The promising results suggest that Biodanza could be a beneficial therapeutic approach for improving the well-being of individuals with Alzheimer's, warranting further effectiveness studies.
Biodanza as a Nonpharmacological Dance Movement-Based Treatment in Older People With Alzheimer's Disease: An Italian Pilot Study in 2 Tuscan Nursing Homes.Chiesi, F., Gori, E., Collini, F., et al.[2023]
A home-based gait training program using rhythmic auditory cues was found to be feasible and safe for individuals with mild to moderate Alzheimer's disease, with no adverse events reported during the study.
Participants showed significant improvements in walking speed and stride length after the 4-week intervention, indicating that music-cued training can help maintain mobility in people living with Alzheimer's.
Home-Based Gait Training Using Rhythmic Auditory Cues in Alzheimer's Disease: Feasibility and Outcomes.Wittwer, JE., Winbolt, M., Morris, ME.[2020]

References

The effects of Salsa dance on balance, gait, and fall risk in a sedentary patient with Alzheimer's dementia, multiple comorbidities, and recurrent falls. [2022]
Biodanza as a Nonpharmacological Dance Movement-Based Treatment in Older People With Alzheimer's Disease: An Italian Pilot Study in 2 Tuscan Nursing Homes. [2023]
Home-Based Gait Training Using Rhythmic Auditory Cues in Alzheimer's Disease: Feasibility and Outcomes. [2020]
Remediation of cognitive and motor functions in Tunisian elderly patients with mild Alzheimer's disease: implications of music therapy and/or physical rehabilitation. [2023]
A physical exercise program using music-supported video-based training in older adults in nursing homes suffering from dementia: a feasibility study. [2019]
Group Balance Training Specifically Designed for Individuals With Alzheimer Disease: Impact on Berg Balance Scale, Timed Up and Go, Gait Speed, and Mini-Mental Status Examination. [2015]
Improvisational Movement to Improve Quality of Life in Older Adults With Early-Stage Dementia: A Pilot Study. [2022]
8.Russia (Federation)pubmed.ncbi.nlm.nih.gov
[Dance therapy in the rehabilitation of neurological diseases]. [2022]
Psychomotor Dance Therapy Intervention (DANCIN) for people with dementia in care homes: a multiple-baseline single-case study. [2019]
10.United Statespubmed.ncbi.nlm.nih.gov
Dance-Specific Activity in People Living With Dementia: A Conceptual Framework and Systematic Review of Its Effects on Neuropsychiatric Symptoms. [2023]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity